Added to YB: 2026-05-21
Pitch date: 2026-05-18
LNSR [bullish]
LENSAR, Inc.
+13.7%
current return
Author Info
Triple S is a professional special situations investor who shares ideas in their newsletter. Sign up for the newsletter.
Company Info
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally.
Market Cap
$74.8M
Pitch Price
$5.62
Price Target
16.75 (+187%)
Dividend
N/A
EV/EBITDA
-6.99
P/E
2.71
EV/Sales
1.35
Sector
Health Care Equipment and Supplies
Category
special_situation
Stock Trade Compilation Episode Siete - LENSAR, Inc.
LNSR: Femtosecond laser systems for cataract surgery w/ installed base generating recurring procedure license rev. Alcon deal at $16.75/share failed on FTC concerns, but strategic value proven. JNJ Vision, Bausch+Lomb, Zeiss potential acquirers. Buying at $5 vs $16.75 takeout validates 3x+ upside on M&A catalyst.
Read full article (1 min)